XML 23 R26.htm IDEA: XBRL DOCUMENT v2.4.0.8
STOCK-BASED COMPENSATION (Tables)
9 Months Ended
Sep. 28, 2013
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Stock- Based Compensation
A summary of award activity under the stock option plans as of September 28, 2013 and changes during the nine month period is as follows (all options were vested as of September 28, 2013):
 
Nine months ended September 28, 2013
 
Shares
 
Weighted
Average
Exercise
Price
Balance, December 29, 2012
983,680

 
$
5.26

Options forfeited/canceled
(145,346
)
 
5.85

Options exercised

 

Balance, all exercisable, September 28, 2013
838,334

 
$
5.16

Stock Options Outstanding and Exercisable
The following table summarizes information about stock options outstanding and exercisable at September 28, 2013:
 
Options Outstanding and Exercisable
Range of Exercise Prices
Number
Outstanding
and
Exercisable
 
Weighted
Average
Remaining
Contractual
Life (Years)
 
Weighted
Average
Exercise
Price
$ 0.01—$ 3.50
130,000

 
2.00
 
$
3.49

$ 3.75—$ 4.82
204,350

 
1.00
 
3.77

$ 5.00—$ 5.29
403,984

 
0.31
 
5.20

$10.00
100,000

 
1.00
 
10.00


838,334

 
0.82
 
$
5.16

Aggregate intrinsic value on September 28, 2013
$
106,427

 

 

NonVested Restricted Common Stock
A summary of the activity for non-vested restricted common stock awards as of September 28, 2013 and changes during the nine month period is presented below:
 
Shares
 
Weighted
Average
Grant
Fair
Value
Balance, December 29, 2012
2,283,048

 
$
4.76

Granted
2,035,000

 
3.22

Forfeited
(177,000
)
 
4.02

Vested
(107,500
)
 
3.55

Balance, September 28, 2013
4,033,548

 
$
4.04

Stock-Based Compensation Expense
The following table summarizes stock-based compensation expense within each of the categories below as it relates to non-vested restricted common stock awards for the nine months ended September 28, 2013 and September 29, 2012 (no tax benefits were recognized):
 
Nine Months Ended
 
September 28,
2013
 
September 29,
2012
Cost of product revenues
$
254,642

 
$
255,357

Research and development
258,187

 
209,531

Selling, general and administrative
3,136,075

 
3,113,042

Total
$
3,648,904

 
$
3,577,930